What is Fubitai COVID-19 vaccine? The booster needle mRNA COVID-19 vaccine has two advantages

The mRNA COVID-19 vaccine "Fubitai" has passed the professional review and is currently stepping up the administrative approval stage. It is reported that the effective rate of Fubitai is 95%, ranking first in the world. Fubitai is expected to become a domestic booster injection. So what is Fubitai COVID-19 vaccine? Below, the editor brings an introduction.

The pace of introducing mRNA COVID-19 vaccine in China is accelerating. Fosun Pharmaceuticals replied to investors' inquiries at the shareholders' meeting and said that the approval of the mRNA COVID-19 vaccine "Fubitai" by the State Food and Drug Administration has been basically completed, the expert review has been passed, and the administrative approval stage is currently being stepped up. Fosun Pharma has already started production preparation work with BioNTech in advance, and once the Fubitake vaccine is approved, it can be supplied to China as soon as possible; According to informed sources, in the future, Fubitai is likely to be used as a booster shot in China, with free vaccination, but this claim has not been officially confirmed yet.

The instructions for the mainland version of Fubitai clearly state that the vaccination target is: this product is suitable for active immunization of people aged 16 and above.

For sequential vaccination, a large number of clinical trials are required to verify its safety and effectiveness, and it can only be carried out after the official launch of Fubitai.

What is Fubitai COVID-19 vaccine

1. It does not bring the risk of infection or mutation;

2. In terms of effectiveness, there are multiple modification methods that can make mRNA more stable and translate more efficiently; The development of simultaneous delivery methods can enable mRNA to be rapidly delivered into cells and exert its function.

Who can't get vaccinated with the Febutane vaccine?

1. For those who are allergic to drugs: If the public has had allergic reactions to Febutane or its active substances or other ingredients, it should not be used. The above active substances or other components include [(4-hydroxybutyl) azetidine] bis (hexane-6,1-diyl) bis (2-hexyldecanoate) (ALC-0315)/2- [(polyethylene glycol) -2000] - N, N-tetradecylacetamide (ALC-0159)/1,2-distearoyl-sn-glycerin-3-phosphate bile base (DSPC)/cholesterol/potassium chloride/potassium dihydrogen phosphate/sodium chloride/disodium hydrogen phosphate dihydrate/sucrose/water for injection.

2. Pregnant women, breast-feeding women and women in preparation for pregnancy: Generally speaking, they should not be regularly vaccinated with neocoronavirus during pregnancy, unless they are at high risk of SARS cov-2 infection or complications after COVID-19 infection. Generally speaking, it is not a routine recommendation for lactating women to receive COVID-19 vaccine, but if women have high clinical needs to prevent COVID-19 during lactation, they can also be vaccinated. If you are a pregnant or breastfeeding woman and believe that you may be pregnant or planning to become pregnant, please consult a doctor before getting vaccinated.

3. This vaccine is only suitable for people over 16 years old and is not suitable for children.

That's all for now. For more exciting content, please continue to follow the editor.